ArticleNature2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.
Matthew Holderfield et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
238 papers cite itlatest 60 shown
this papertrialcites it
ArticleNature2024
Matthew Holderfield et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.